Your browser doesn't support javascript.
loading
Inhibition of stem-like cells proliferation and programmed cell death-ligand 1 expression by blocking transforming growth factor-ß1 signaling pathway in angiosarcoma.
Li, Zeying; Jin, Shan; Lyu, Yanmin; Guo, Na; Li, Qiuxiang; Cai, Wenping; Du, Jin; Qiu, Jin; Xu, Tong; Zhao, Kai; Pang, Lijuan.
Afiliação
  • Li Z; Department of Pathology, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, ZhanjiangGuangdong, 524000, China.
  • Jin S; Department of Pathology, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, ZhanjiangGuangdong, 524000, China.
  • Lyu Y; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases (First Affiliated Hospital, School of Medicine, Shihezi University)/Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, 832002, Xinj
  • Guo N; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases (First Affiliated Hospital, School of Medicine, Shihezi University)/Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, 832002, Xinj
  • Li Q; Lianyuan People's Hospital, Hunan, China.
  • Cai W; Department of Pathology, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, ZhanjiangGuangdong, 524000, China.
  • Du J; Department of Pathology, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, ZhanjiangGuangdong, 524000, China.
  • Qiu J; Department of Clinical Laboratory, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, Zhanjiang, Guangdong, China.
  • Xu T; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases (First Affiliated Hospital, School of Medicine, Shihezi University)/Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, 832002, Xinj
  • Zhao K; NHC Key Laboratory of Prevention and Treatment of Central Asia High Incidence Diseases (First Affiliated Hospital, School of Medicine, Shihezi University)/Department of Pathology and Key Laboratory for Xinjiang Endemic and Ethnic Diseases, Shihezi University School of Medicine, Shihezi, 832002, Xinj
  • Pang L; Department of Pathology, Central People's Hospital of Zhanjiang and Zhanjiang Central Hospital, Guangdong Medical University, ZhanjiangGuangdong, 524000, China. ocean123456@163.com.
Arch Dermatol Res ; 316(6): 209, 2024 May 24.
Article em En | MEDLINE | ID: mdl-38787445
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Transdução de Sinais / Proliferação de Células / Fator de Crescimento Transformador beta1 / Antígeno B7-H1 / Hemangiossarcoma Limite: Humans Idioma: En Revista: Arch Dermatol Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Transdução de Sinais / Proliferação de Células / Fator de Crescimento Transformador beta1 / Antígeno B7-H1 / Hemangiossarcoma Limite: Humans Idioma: En Revista: Arch Dermatol Res Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China